top of page
vaxa_logo_FF0000_transparent.png
LET'S TALK
vaxa_logo_FF0000_transparent.png
LET'S TALK

Thinking you can put to work.

Proprietary insights, expert analyses and bold thinking for leaders who want to achieve short and long term consistent tangible results.

Tattoo Application Process

Mastering CVC — Driving Innovation and Growth

A venture program pays off when it starts from strategy, not from the size of the fund. Here is the playbook for getting it right, off the bat — whether you're small, medium or large.

LEARN ABOUT IT
EXPLORE VAXA CVC

From The Works is Vaxa's methodology insights. Each article draws on real client work to explain a framework, approach, or analytical method that produces client results. FTW articles are not case studies — they do not describe a specific engagement in detail.

Mastering CVC — Driving Innovation and Growth

A venture program pays off when it starts from strategy, not from the size of the fund.

The Assets Were There. The Framework Wasn't.

Proprietary capability often never leaves the division that built it. The constraint isn't the technology — it's the missing transfer framework.

Entries That Try to Do Everything at Once Rarely Survive First Contact.

Broad-launch entries rarely survive. A foundational 1991 book explains why narrow works better — and why it's hard to follow.

READ ALL FROM THE WORKS

From The Works is Vaxa's methodology insights. Each article draws on real client work to explain a framework, approach, or analytical method that produces client results. FTW articles are not case studies — they do not describe a specific engagement in detail.

Points of View articles state a position on a question where reasonable people disagree — and makes the argument for that position as directly as possible.

A $440,000 client deliverable came back full of fake citations. The firm refunded part of the fee. No one was named accountable.

READ

A century of film has predicted real technology and social shifts with unsettling accuracy -- and almost no corporate strategy function is watching it systematically.

READ

69% of Asia-Pacific CEOs and 50% of European CEOs are shifting hiring away from junior roles. The training ground for future senior judgment is going with it.

READ
READ ALL POINTS OF VIEW

What We Are Watching is Vaxa's signal intelligence column. Article identifies a market, technology, or structural shift that is already in motion but has not yet reached a heightened sense of urgency

Drug development is becoming a continuously learning system. Most of the ecosystem around it was built for a linear one.

READ

The healthcare conversation has dominated. The downstream effects on consumer spending are only beginning to surface.

READ

Everyone is watching quantum for the wrong application.

READ
READ ALL WHAT WE ARE WATCHING

Sector Lens are comprehensive assessments — the forces driving change, who is positioned well, who is exposed, and what the strategic questions are for organizations operating in the sector. They are evidence-based and designed to stand alone as leadership articles.

Moisturizing Skin Close-Up

Only 10.9% of founder-led companies that reach $1B ever cross $10B. The rest aren't failing. They're freezing.

Read
READ ALL SECTOR LENSVAXA FOR FOUNDERS

Case studies describe real client engagements at the level of detail that client confidentiality permits: the nature of the problem, the approach Vaxa took, and the outcome. Names are not disclosed. The thinking is.

Moisturizing Skin Close-Up

A Fortune 500 technology company. A structural shift forming in life sciences. A bottom-up market sizing no one had attempted. And a $100 million commitment within six months.

Read
ABOUT GROWTH STRATEGY

The signals that will shape your next five years are already out there. The advantage goes to those who read them well.

Get new Insights by email.

START A CONVERSATION
bottom of page